Logo image of C5H.I

CAIRN HOMES PLC (C5H.I) Stock Fundamental Analysis

DUB:C5H - Euronext Dublin - IE00BWY4ZF18 - Common Stock - Currency: EUR

2.23  +0.01 (+0.45%)

Fundamental Rating

7

Overall C5H gets a fundamental rating of 7 out of 10. We evaluated C5H against 35 industry peers in the Household Durables industry. C5H has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. C5H is not valued too expensively and it also shows a decent growth rate. These ratings would make C5H suitable for quality investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

C5H had positive earnings in the past year.
C5H had a positive operating cash flow in the past year.
In the past 5 years C5H has always been profitable.
C5H had a positive operating cash flow in 4 of the past 5 years.
C5H.I Yearly Net Income VS EBIT VS OCF VS FCFC5H.I Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200M -400M

1.2 Ratios

C5H's Return On Assets of 10.68% is amongst the best of the industry. C5H outperforms 88.57% of its industry peers.
C5H's Return On Equity of 15.11% is fine compared to the rest of the industry. C5H outperforms 77.14% of its industry peers.
With a decent Return On Invested Capital value of 13.73%, C5H is doing good in the industry, outperforming 80.00% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for C5H is significantly below the industry average of 16.45%.
The 3 year average ROIC (11.22%) for C5H is below the current ROIC(13.73%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 10.68%
ROE 15.11%
ROIC 13.73%
ROA(3y)8.93%
ROA(5y)6.46%
ROE(3y)12.39%
ROE(5y)8.88%
ROIC(3y)11.22%
ROIC(5y)8.33%
C5H.I Yearly ROA, ROE, ROICC5H.I Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15

1.3 Margins

Looking at the Profit Margin, with a value of 13.32%, C5H belongs to the top of the industry, outperforming 91.43% of the companies in the same industry.
C5H's Profit Margin has improved in the last couple of years.
C5H has a better Operating Margin (17.45%) than 91.43% of its industry peers.
In the last couple of years the Operating Margin of C5H has grown nicely.
Looking at the Gross Margin, with a value of 21.74%, C5H is doing worse than 74.29% of the companies in the same industry.
In the last couple of years the Gross Margin of C5H has grown nicely.
Industry RankSector Rank
OM 17.45%
PM (TTM) 13.32%
GM 21.74%
OM growth 3Y8.2%
OM growth 5Y2.23%
PM growth 3Y9.36%
PM growth 5Y2.53%
GM growth 3Y3.19%
GM growth 5Y2.1%
C5H.I Yearly Profit, Operating, Gross MarginsC5H.I Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), C5H is creating value.
The number of shares outstanding for C5H has been reduced compared to 1 year ago.
Compared to 5 years ago, C5H has less shares outstanding
C5H has a worse debt/assets ratio than last year.
C5H.I Yearly Shares OutstandingC5H.I Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
C5H.I Yearly Total Debt VS Total AssetsC5H.I Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

An Altman-Z score of 5.67 indicates that C5H is not in any danger for bankruptcy at the moment.
C5H has a better Altman-Z score (5.67) than 91.43% of its industry peers.
The Debt to FCF ratio of C5H is 1.45, which is an excellent value as it means it would take C5H, only 1.45 years of fcf income to pay off all of its debts.
C5H has a better Debt to FCF ratio (1.45) than 88.57% of its industry peers.
C5H has a Debt/Equity ratio of 0.23. This is a healthy value indicating a solid balance between debt and equity.
C5H has a better Debt to Equity ratio (0.23) than 68.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 1.45
Altman-Z 5.67
ROIC/WACC1.85
WACC7.42%
C5H.I Yearly LT Debt VS Equity VS FCFC5H.I Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M 600M

2.3 Liquidity

C5H has a Current Ratio of 7.53. This indicates that C5H is financially healthy and has no problem in meeting its short term obligations.
C5H has a better Current ratio (7.53) than 100.00% of its industry peers.
C5H has a Quick Ratio of 1.31. This is a normal value and indicates that C5H is financially healthy and should not expect problems in meeting its short term obligations.
C5H's Quick ratio of 1.31 is fine compared to the rest of the industry. C5H outperforms 77.14% of its industry peers.
Industry RankSector Rank
Current Ratio 7.53
Quick Ratio 1.31
C5H.I Yearly Current Assets VS Current LiabilitesC5H.I Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

6

3. Growth

3.1 Past

C5H shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 40.71%, which is quite impressive.
Measured over the past years, C5H shows a very strong growth in Earnings Per Share. The EPS has been growing by 20.48% on average per year.
Looking at the last year, C5H shows a very strong growth in Revenue. The Revenue has grown by 28.95%.
Measured over the past years, C5H shows a quite strong growth in Revenue. The Revenue has been growing by 14.59% on average per year.
EPS 1Y (TTM)40.71%
EPS 3Y43.61%
EPS 5Y20.48%
EPS Q2Q%9.87%
Revenue 1Y (TTM)28.95%
Revenue growth 3Y26.58%
Revenue growth 5Y14.59%
Sales Q2Q%10.39%

3.2 Future

C5H is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.92% yearly.
C5H is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.07% yearly.
EPS Next Y11.29%
EPS Next 2Y8.7%
EPS Next 3Y6.92%
EPS Next 5YN/A
Revenue Next Year10.74%
Revenue Next 2Y7.73%
Revenue Next 3Y6.07%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
C5H.I Yearly Revenue VS EstimatesC5H.I Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
C5H.I Yearly EPS VS EstimatesC5H.I Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.05 0.1 0.15 0.2

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 12.39, which indicates a correct valuation of C5H.
C5H's Price/Earnings ratio is a bit cheaper when compared to the industry. C5H is cheaper than 62.86% of the companies in the same industry.
C5H's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.48.
The Price/Forward Earnings ratio is 10.81, which indicates a very decent valuation of C5H.
C5H's Price/Forward Earnings is on the same level as the industry average.
C5H is valuated cheaply when we compare the Price/Forward Earnings ratio to 34.04, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 12.39
Fwd PE 10.81
C5H.I Price Earnings VS Forward Price EarningsC5H.I Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, C5H is valued a bit more expensive than 62.86% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, C5H is valued a bit cheaper than the industry average as 71.43% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 10.71
EV/EBITDA 10.15
C5H.I Per share dataC5H.I EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of C5H may justify a higher PE ratio.
PEG (NY)1.1
PEG (5Y)0.6
EPS Next 2Y8.7%
EPS Next 3Y6.92%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.83%, C5H has a reasonable but not impressive dividend return.
C5H's Dividend Yield is a higher than the industry average which is at 4.80.
Compared to an average S&P500 Dividend Yield of 2.40, C5H pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.83%

5.2 History

On average, the dividend of C5H grows each year by 23.30%, which is quite nice.
Dividend Growth(5Y)23.3%
Div Incr Years3
Div Non Decr Years3
C5H.I Yearly Dividends per shareC5H.I Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.02 0.04 0.06

5.3 Sustainability

39.03% of the earnings are spent on dividend by C5H. This is a low number and sustainable payout ratio.
C5H's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP39.03%
EPS Next 2Y8.7%
EPS Next 3Y6.92%
C5H.I Yearly Income VS Free CF VS DividendC5H.I Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200M -400M
C5H.I Dividend Payout.C5H.I Dividend Payout, showing the Payout Ratio.C5H.I Dividend Payout.PayoutRetained Earnings

CAIRN HOMES PLC

DUB:C5H (8/8/2025, 7:00:00 PM)

2.23

+0.01 (+0.45%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)02-27 2025-02-27/amc
Earnings (Next)09-03 2025-09-03
Inst Owners77.29%
Inst Owner ChangeN/A
Ins Owners3.77%
Ins Owner ChangeN/A
Market Cap1.40B
Analysts83.64
Price Target2.47 (10.76%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.83%
Yearly Dividend0.07
Dividend Growth(5Y)23.3%
DP39.03%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.22%
PT rev (3m)2.13%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.71%
Valuation
Industry RankSector Rank
PE 12.39
Fwd PE 10.81
P/S 1.62
P/FCF 10.71
P/OCF 10.36
P/B 1.84
P/tB 1.85
EV/EBITDA 10.15
EPS(TTM)0.18
EY8.07%
EPS(NY)0.21
Fwd EY9.25%
FCF(TTM)0.21
FCFY9.34%
OCF(TTM)0.22
OCFY9.65%
SpS1.37
BVpS1.21
TBVpS1.2
PEG (NY)1.1
PEG (5Y)0.6
Profitability
Industry RankSector Rank
ROA 10.68%
ROE 15.11%
ROCE 16.07%
ROIC 13.73%
ROICexc 14.15%
ROICexgc 14.22%
OM 17.45%
PM (TTM) 13.32%
GM 21.74%
FCFM 15.15%
ROA(3y)8.93%
ROA(5y)6.46%
ROE(3y)12.39%
ROE(5y)8.88%
ROIC(3y)11.22%
ROIC(5y)8.33%
ROICexc(3y)11.53%
ROICexc(5y)8.59%
ROICexgc(3y)11.58%
ROICexgc(5y)8.63%
ROCE(3y)13.13%
ROCE(5y)9.75%
ROICexcg growth 3Y32.35%
ROICexcg growth 5Y16.05%
ROICexc growth 3Y32.21%
ROICexc growth 5Y15.96%
OM growth 3Y8.2%
OM growth 5Y2.23%
PM growth 3Y9.36%
PM growth 5Y2.53%
GM growth 3Y3.19%
GM growth 5Y2.1%
F-Score6
Asset Turnover0.8
Health
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 1.45
Debt/EBITDA 1.13
Cap/Depr 161.25%
Cap/Sales 0.51%
Interest Coverage 10.07
Cash Conversion 88.17%
Profit Quality 113.69%
Current Ratio 7.53
Quick Ratio 1.31
Altman-Z 5.67
F-Score6
WACC7.42%
ROIC/WACC1.85
Cap/Depr(3y)261.68%
Cap/Depr(5y)199.51%
Cap/Sales(3y)0.79%
Cap/Sales(5y)0.56%
Profit Quality(3y)113.52%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)40.71%
EPS 3Y43.61%
EPS 5Y20.48%
EPS Q2Q%9.87%
EPS Next Y11.29%
EPS Next 2Y8.7%
EPS Next 3Y6.92%
EPS Next 5YN/A
Revenue 1Y (TTM)28.95%
Revenue growth 3Y26.58%
Revenue growth 5Y14.59%
Sales Q2Q%10.39%
Revenue Next Year10.74%
Revenue Next 2Y7.73%
Revenue Next 3Y6.07%
Revenue Next 5YN/A
EBIT growth 1Y32.29%
EBIT growth 3Y36.95%
EBIT growth 5Y17.14%
EBIT Next Year9.34%
EBIT Next 3Y5.93%
EBIT Next 5YN/A
FCF growth 1Y26.55%
FCF growth 3Y14.39%
FCF growth 5Y5.88%
OCF growth 1Y25.83%
OCF growth 3Y15.01%
OCF growth 5Y6.31%